Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
VSY Biotechnology’s SVT Granted Patent in China
VSY Biotechnology registered a patent with the People’s Republic of China for the ‘Sinusoidal Vision Technology’ used in AcrivaUD Trinova Pro C Pupil Adaptive®, the world’s first and only sinusoidal trifocal intraocular lens. As a result of evaluations, office actions,…
Use of Telemedicine in Ophthalmology
The medical industry is undergoing radical change as we enter the digital age. One such change is the advent of telemedicine – a powerful tool enabling healthcare providers to connect with patients remotely. Ophthalmology, the branch of medicine dedicated to…
DORC Receives FDA Clearance for Eva Nexus System
DORC International has announced 510(k) market clearance and the launch of the Eva Nexus. According to DORC, the Eva Nexus features multiple innovations to improve performance, efficiency, and stability for retina surgeons, including Smart IOP for anterior and posterior chamber stability; DORC’s trocar cannula system with HI-FLOW infusion…
Metformin Found Ineffective Against Geographic Atrophy
In the quest to find effective treatments for eye diseases, the METformin for the MINimization of Geographic Atrophy Progression (METforMIN) trial sought to evaluate the efficacy of oral metformin in slowing the progression of geographic atrophy (GA) and its effects…
New Device Targets Dry Eye and Beyond with Thermal Imaging
A groundbreaking innovation in ocular health assessment is on the horizon, as a new University of Waterloo spinoff company, ThermOcular AI, unveils its pioneering approach to eye temperature monitoring. Transforming Ocular Diagnostics Founded by vision science and engineering researchers from…
Melt Pharmaceuticals Launches MELT-300 Phase 3 Program
Melt Pharmaceuticals has completed the dosing of its first patient in its phase 3 program for MELT-300, marking a crucial step in evaluating the safety and efficacy of this pioneering product. MELT-300 is a non-intravenous, non-opioid tablet comprising fixed doses…
Rayner Announces 3 Key Appointments to Management Board
Rayner has made three key additions to its management board to foster continued growth and development within the organization. James Crutchlow has been appointed as Chief Commercial Officer, Rob Nadler as Chief Growth Officer, and Chris Willis as Chief Marketing…
Eversight Partners with LighTopTech to Improve Eye Imaging
Eversight has partnered up with LighTopTech to elevate the standards of imaging modalities for eye tissues. This ambitious partnership, spanning over four years, sets out to redefine the landscape of ocular imaging in both clinical and research domains. LighTopTech’s OCX…
CorneaGen Launches CTAK for Keratoconus Patients
CorneaGen, a leading provider of ocular tissue, announced the commercial launch of Corneal Tissue Addition for Keratoplasty (CTAK), a novel solution for corneal contouring in keratoconic eyes. Developed in collaboration with CTAK LLC and Ziemer, CTAK offers patient-ready, gamma-irradiated sterile…
BIOPHTA Secures €6.5M to Advance Eye Disease Therapy
BIOPHTA, a preclinical biotech company, has successfully closed a Seed round, raising €6.5 million to advance its pioneering technology into clinical development for the treatment of glaucoma and macular edema. This significant funding injection, led by prominent European venture capital…